The Centers for Disease Control and Prevention (CDC) today issued the first FluView influenza activity report for the U.S. 2012-2013 flu season. The 2012-2013 reporting season began on Sept. 30, 2012. The first FluView report shows that influenza activity is low nationwide.Â
The CDC routinely tracks influenza activity in the United States with a system that determines when and where influenza activity is occurring, what influenza viruses are circulating, and detects changes in influenza viruses. The system also measures the burden of influenza disease in the United States, including tracking flu-related illness, hospitalizations and deaths. Data for the week ending Oct. 6, 2012 indicate that influenza activity is low nationally at this time.
This year, FluView includes enhanced web-based interactive applications, which can provide dynamic visuals of the influenza data collected and analyzed by CDC. These FluView Interactive applications allow people to create customized, visual interpretations of influenza data, as well as comparisons across flu seasons, regions, age groups, and a variety of other demographics.
CDC experts cant predict how severe the upcoming flu season will be. However, the agency recommends that everyone 6 months of age and older get vaccinated against influenza each year. More than 112 million doses of seasonal influenza vaccine already have been distributed by vaccine manufacturers in the United States this season and more is expected.Â
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.